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treatment for all gynaecological patients using CBCT. 
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Purpose/Objective: To analyse 4 field conventional 
radiotherapy (4FRT), intensity modulated radiotherapy (IMRT) 
and volumetric modulated arc therapy (VMAT) in the 
definitive management of cervix cancer and to assess 
whether any dosimetric differences persist with the use of 
larger geometric PTV margins to account for daily variability 
in uterine position. 
Materials and Methods: CT datasets were obtained for 20 
consecutive patients with intact cervix cancer previously 
treated with definitive external beam radiotherapy (with or 
without chemotherapy). The clinical target volume was 
contoured to encompass gross tumour and potential 
microscopic disease including the remaining cervix, uterus, 
upper vagina, parametrium, adnexa and regional lymph 
nodes. The planning target volume (PTV) was generated with 
uterine margins of 1.5cm, 2cm, 2.5cm, 3cm and 4cm used to 
account for internal motion of the uterus, generating five 
PTVs for each patient: PTV1.5, PTV2, PTV2.5, PTV3 and 
PTV4. The rectum, bladder, bowel and femoral heads were 
contoured as organs at risk (OARs). For each patient, a 4FRT 
plan was generated based on conventional field borders 
ensuring coverage of PTV1.5. IMRT and VMAT plans were 
generated for each PTV, except when the PTV extended 
outside 4FRT fields. Prescription dose was 45Gy in 25 
fractions. Plans were evaluated for target coverage, 
conformity, dose homogeneity and dose to OARs. Planning 
time, total monitor units and estimated delivery time were 
also evaluated. 
Results: The median patient age was 56 years (range: 27-84 
years). Stage 1, 2, 3 and 4A disease was seen in 1, 12, 4 and 
3 patients respectively with nodal involvement in 13 patients. 
PTV2.5, PTV3 and PTV4 extended outside the 4FRT fields in 9 
(45%), 13 (65%) and 20 (100%) patients respectively. Target 
coverage was excellent for the 4FRT, IMRT and VMAT plans 
generated, with no significant difference between 
techniques, however, IMRT and VMAT plans were associated 
with a reduction in dose to OARs compared to 4FRT. Mean 
monitor units was lowest with 4FRT, followed by VMAT then 
IMRT.  
Conclusions: IMRT and VMAT are associated with dosimetric 
advantages over 4FRT when margins less than 3cm are used, 
with exceptional target coverage and superior OAR sparing. 
Uterine margins of 3cm or greater commonly resulted in the 
PTV extending outside conventional radiotherapy fields, 
demonstrating no benefit for these advanced planning 
techniques in patients with large variation in uterine 
position. Furthermore, accurate uterine localisation with 
image guidance is critical when considering implementation 
of IMRT or VMAT for cervix cancer treatment. Prospective 
studies are also needed to verify that these newer techniques 
reduce the rates of acute and late toxicities without 
compromising long-term disease control. 
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Purpose/Objective: Evaluate the diagnostic capabilities of 
MRI in the detection of neoplastic lesions of the vagina, as 
well as to optimize the protocol complex MR examination of 
the pelvic organs in clinical use in the planning and 
monitoring of HDR brachytherapy in patients with gynecologic 
cancer with primary or metastatic lesions of the vagina. 
Materials and Methods: With the purpose assess the state of 
the vagina performed 179 MR studies of the pelvic organs in 
108 women with gynecologic cancer, mean age was 58.5 
years. In order to volumetric 3D-planning performed 56 MR 
studies 31 patients with primary and metastatic tumors of 
the vagina treated with brachytherapy in automated complex 
'Microselektron HDR», equipped with isotope 192Ir, using the 
planning system Oncentra Brachy (Nucletron®). Complex MRI 
(Toshiba Vantage Atlas, 1,5 T) pelvic examinations with 
contrast enhancement consisted of native scanning, DWI, 
dynamic contrast enhanced (DCE) examination with 
additional endovaginal MR-compatible applicator 
introduction. All patients previously carried out at different 
times external beam radiotherapy with a total boost dose 46-
60Gr. Re-planning during treatment was performed in 23 
patients. In ultrasonography study to delineate the 
boundaries of the tumor visualized in 62.5% of cases; in CT 
imaging - in 37.5%. For planning we used colpostat diameter 
of 20 mm. 
Results: Neoplastic lesions in vagina were found during 
complex MRI (CMRI) in 58 (51,7%) pts, at lower third - in 5 
(8,6%), as endometrial and vulvar cancer progression, at 
middle third - in 11 (18,9%) pts, at upper third - in 42 
(72,4%), included 18 (31%) pts with vaginal cuff relapse. It 
was revealed as a zone with increasing signal in T2-weighted 
sequence and contrast accumulation in the arterial and 
venous phases. Differential diagnosis with post-radiation 
fibrosis demanded image fusion of T2WI fat sat, DWI and DCE 
with endovaginal MR-suitable applicator, which created 
conditions for better visualization of vaginal wall structure 
and tumor localization because of fold smoothing. In all 
cases, MRI was able to determine the boundaries of the 
tumor process necessary for contouring. At the same time 
25% of patients with symptoms of tumor progression (MRI), 
intimate adhere to vaginal tumors of the bladder or rectum 
involving retro-vesicle, recto-vaginal tissue, demanded 
change of treatment programs, the volume of irradiation, the 
planned total doses, but did not result in rejection of a 
planned rate brachytherapy. According to the dynamic MRI 
performed during the course of radiotherapy, more than 50% 
regression of tumor volume was determined in 50% of 
patients, which in some cases entailed a change in the 
volume of targeted areas.  
Conclusions: CMRI increases the accuracy of primary and 
recurrent vaginal tumors determination and treatment results 
